Tisdag 18 Augusti | 19:57:46 Europe / Stockholm
Est. tid*
2027-02-17 07:00 Bokslutskommuniké 2026
2026-11-11 07:00 Kvartalsrapport 2026-Q3
2026-08-19 07:00 Kvartalsrapport 2026-Q2
2026-05-08 - X-dag ordinarie utdelning BICO 0.00 SEK
2026-05-07 - Årsstämma
2026-04-29 - Kvartalsrapport 2026-Q1
2026-02-18 - Bokslutskommuniké 2025
2025-11-04 - Kvartalsrapport 2025-Q3
2025-08-19 - Kvartalsrapport 2025-Q2
2025-05-09 - X-dag ordinarie utdelning BICO 0.00 SEK
2025-05-08 - Årsstämma
2025-04-29 - Kvartalsrapport 2025-Q1
2025-02-19 - Bokslutskommuniké 2024
2024-11-26 - Kvartalsrapport 2024-Q3
2024-08-20 - Kvartalsrapport 2024-Q2
2024-05-21 - X-dag ordinarie utdelning BICO 0.00 SEK
2024-05-20 - Årsstämma
2024-05-07 - Kvartalsrapport 2024-Q1
2024-02-20 - Bokslutskommuniké 2023
2023-11-14 - Kvartalsrapport 2023-Q3
2023-08-22 - Kvartalsrapport 2023-Q2
2023-05-10 - X-dag ordinarie utdelning BICO 0.00 SEK
2023-05-09 - Årsstämma
2023-05-04 - Kvartalsrapport 2023-Q1
2023-02-22 - Bokslutskommuniké 2022
2022-12-14 - Extra Bolagsstämma 2022
2022-11-09 - Kvartalsrapport 2022-Q3
2022-08-24 - Kvartalsrapport 2022-Q2
2022-05-18 - Kvartalsrapport 2022-Q1
2022-04-27 - X-dag ordinarie utdelning BICO 0.00 SEK
2022-04-26 - Årsstämma
2022-02-23 - Bokslutskommuniké 2021
2021-11-17 - Extra Bolagsstämma 2021
2021-11-10 - Kvartalsrapport 2021-Q3
2021-08-18 - Kvartalsrapport 2021-Q2
2021-05-12 - Kvartalsrapport 2021-Q1
2021-04-27 - X-dag ordinarie utdelning BICO 0.00 SEK
2021-04-26 - Årsstämma
2021-02-25 - Bokslutskommuniké 2020
2020-12-18 - X-dag ordinarie utdelning BICO 0.00 SEK
2020-12-17 - Extra Bolagsstämma 2020
2020-10-22 - Kvartalsrapport 2020-Q3
2020-04-09 - Kvartalsrapport 2020-Q2
2020-01-20 - Kvartalsrapport 2020-Q1
2020-01-10 - Split BICO 1:4
2019-12-19 - X-dag ordinarie utdelning BICO 0.00 SEK
2019-12-18 - Årsstämma
2019-10-24 - Bokslutskommuniké 2019
2019-08-26 - Extra Bolagsstämma 2019
2019-07-11 - Kvartalsrapport 2019-Q3
2019-04-10 - Kvartalsrapport 2019-Q2
2018-12-14 - X-dag ordinarie utdelning BICO 0.00 SEK
2018-12-13 - Årsstämma
2018-10-24 - Bokslutskommuniké 2018
2018-07-11 - Kvartalsrapport 2018-Q3
2018-04-11 - Kvartalsrapport 2018-Q2
2018-01-17 - Kvartalsrapport 2018-Q1
2017-12-15 - X-dag ordinarie utdelning BICO 0.00 SEK
LandSverige
ListaMid Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
BICO Group är verksamt inom bioteknikbranschen och fokuserar på utveckling och tillverkning av teknologier för cellbaserad forskning och medicinsk utveckling. Bolagets produkter riktar sig till forskare och läkemedelsbolag. Verksamheten är global med en huvudsaklig närvaro i Europa, Nordamerika och Asien. BICO Group grundades år 2016 och har sitt huvudkontor i Göteborg.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Anders Fogelberg appointed President and CEO of BICO Group AB

2026-08-18 18:14:00

The Board of Directors of BICO Group AB today announces the appointment of Anders Fogelberg, currently Chief Commercial Officer, as President and CEO, effective September 1, 2026. The Board of Directors have, in a constructive dialogue together with the current President and CEO, Maria Forss, concluded that the time is right for a leadership change. Maria Forss will leave the position on August 31, 2026, and transition into a senior advisory role to support a seamless handover until November 30, 2026.

The Board of Directors have, in a constructive dialogue together with Maria Forss, concluded that the timing is right for a leadership change as the company is entering its next phase of development with an amplified focus on commercialization, customer engagement and profitable growth.

“On behalf of the Board of Directors, I am pleased to welcome Anders Fogelberg as President and CEO. He is an accomplished executive bringing a strong combination of leadership experience, commercial expertise, and a passion for life science innovation, all of which will be instrumental to BICO during its next phase of development,” says Erik Gatenholm, Chairman of the Board.

Anders Fogelberg brings extensive international leadership experience from senior management positions in industrial, medtech, and life science companies, including SKF, Bellman & Symfon and Profundus. He joined BICO in June 2024 as the Chief Commercial Officer and has been a member of the company’s Executive Management Team ever since.

“Since joining BICO’s Executive Management Team as Chief Commercial Officer in 2024, Anders Fogelberg has played a vital role in driving global commercial execution, and advancing key market positions. The Board of Directors have full confidence in his ability to lead the company into its next phase with a clear focus on commercial expansion, operational execution, and profitable growth,” says Erik Gatenholm.

“I would also like to thank Maria Forss for all of her contributions and dedication to BICO. Thanks to Maria Forss, the company stands on firmer ground and is better positioned for the next phase of development. Maria Forss has played an important role in strengthening BICO’s financial position, improving operational discipline, and integrating acquired companies into a more streamlined organization. On behalf of the Board of Directors, I would like to wish her all the success in the future,” continues Erik Gatenholm.

The leadership change does not affect BICO’s overall strategic direction, operational priorities, financial objectives, or commitments to customers, partners and shareholders.